Biogen INC BIOGEN INC ORD SHS/ US09062X1037 /
24.05.2024 18:25:10 | Diff. - | Volumen | Geld06:00:09 | Brief06:00:09 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
218,75USD | - | 1.014 Umsatz: 110.398,48 |
-Geld Vol: - | -Brief Vol: - | 29,83 Mrd.USD | - | 25,53 |
Aktiva
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Sachanlagen | 3.182,4000 | 3.601,2000 | 3.247,3000 | 3.411,5000 | 3.416,4000 | ||||||
Immaterielle Vermögensgegenstände | 3.879,6000 | 3.120 | 3.527,4000 | 3.084,3000 | 2.221,3000 | ||||||
Finanzanlagen | 3.057,3000 | 1.375,9000 | 1.408,1000 | 772,1000 | 892 | ||||||
Anlagevermögen | 15.779,3000 | 17.648 | 18.852,5000 | 17.731,8000 | 16.020,8000 | ||||||
Vorräte | 902,7000 | 929,9000 | 804,2000 | 1.068,6000 | 1.351,5000 | ||||||
Forderungen | 1.787 | 1.958,5000 | 1.880,5000 | 1.913,8000 | 1.549,4000 | ||||||
Liquide Mitteln | 1.573,8000 | 1.224,6000 | 2.913,7000 | 1.331,2000 | 2.261,4000 | ||||||
Umlaufvermögen | 7.873,3000 | 7.640,9000 | 8.381,8000 | 6.887,1000 | 7.856,5000 | ||||||
Aktiva, gesamt | 23.652,6000 | 25.288,9000 | 27.234,3000 | 24.618,9000 | 23.877,3000 |
Passiva
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Verbindlichkeiten aus Lieferungen und Leistungen | 395,5000 | 370,5000 | 530,8000 | 454,9000 | 589,2000 | ||||||
Langfristige Schulden | 5.935 | 5.936,5000 | 4.459 | 7.426,2000 | 6.274 | ||||||
Verbindlichkeiten gegenüber Kreditinstituten | 5.935 | 5.936,5000 | 4.459 | 7.426,2000 | 6.274 | ||||||
Rückstellungen | 190,8000 | 1.699,7000 | 2.882,2000 | 1.174,8000 | 869,2000 | ||||||
Verbindlichkeiten | 11.054,5000 | 12.257,3000 | 13.895,2000 | 13.932,8000 | 12.917,6000 | ||||||
Gezeichnetes Kapital | ,1000 | ,1000 | ,1000 | ,1000 | ,1000 | ||||||
Eigenkapital | 12.598,1000 | 13.031,6000 | 13.339,1000 | 10.686,1000 | 10.959,7000 | ||||||
Minderheitenanteile | -14,7000 | -8 | -4,1000 | -14,2000 | 63,5000 | ||||||
Passiva, gesamt | 23.652,6000 | 25.288,9000 | 27.234,3000 | 24.618,9000 | 23.877,3000 |
Gewinn- und Verlustrechnung
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Umsatzerlöse | 12.273,9000 | 13.452,9000 | 14.377,9000 | 13.444,6000 | 10.981,7000 | ||||||
Abschreibungen (Gesamt) | 1.081 | 1.016,6000 | 680,6000 | 457,2000 | 487,7000 | ||||||
Betriebsergebnis | 5.344,2000 | 5.888,6000 | 7.042,6000 | 4.550,1000 | 2.840,7000 | ||||||
Zinsergebnis | -172,3000 | -88,1000 | -67,4000 | -180,5000 | -242,6000 | ||||||
Ergebnis vor Steuern | 5.128,8000 | 5.899,6000 | 7.125,9000 | 5.047,5000 | 1.745,2000 | ||||||
Ertragsteuern | 2.458,7000 | 1.425,6000 | 1.158 | 992,3000 | 52,5000 | ||||||
Gewinnanteil Minderheitsgesellschafter | 131 | 43,3000 | 0.0000 | 59,9000 | 171,5000 | ||||||
Konzernjahresüberschuss | 2.539,1000 | 4.430,7000 | 5.888,5000 | 4.000,6000 | 1.556,1000 |
Pro Aktie
Cash Flow
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow aus laufender Geschäftstätigkeit | 4.551 | 6.187,7000 | 7.078,6000 | 4.229,8000 | 3.639,9000 | ||||||
Cash Flow aus Investitionstätigkeit | -2.963,1000 | -2.046,3000 | 470,5000 | -608,6000 | -563,7000 | ||||||
Cash Flow aus Finanzierungstätigkeit | -2.380 | -4.472 | -5.860,4000 | -5.272,7000 | -2.086,2000 | ||||||
Veränderung der liquiden Mittel | -792,1000 | -330,6000 | 1.688,7000 | -1.651,5000 | 990 | ||||||
Anzahl der Mitarbeiter | 7.300 | 7.800 | 7.400 | 9.100 | 9.610 |